Loyola is one of two hospitals in Illinois that can simultaneously screen 20 pathogens in 60 minutes for accurate, fast diagnosis of the flu and other respiratory illnesses, saving health, time and money.
A Saint Louis University study finds many U.S. schools are not prepared for bioterrorism attacks, outbreaks of emerging infectious diseases or pandemics.
Patients with severe 2009 H1N1 influenza who developed respiratory failure and were treated with a system that adds oxygen to the patient's blood had a lower rate of in-hospital death than similar patients who did not receive this treatment, according to a study appearing in JAMA.
An analysis of the high incidence of the H1N1 swine-origin influenza virus (S-OIV) in 2009 in the Campania region of Southern Italy presents important findings that provide a “significant pattern for emerging viral agents at risk in global health approaches to early diagnosis and prompt therapy,” according to an article in the Journal of Cellular Physiology.
Be immunized against the flu every year to protect yourself and those around you.
H1N1 and seasonal flu vaccines do not put patients at risk for neurologic conditions, a large new study shows.
In the current issue of Journal of Public Health Management and Practice, public health experts assert that improved community engagement is needed to prevent the spread of pandemics. The observations are based on an assessment of distribution and vaccination trends for the H1N1 vaccine in Los Angeles County in 2009, with a special focus on the African American community. The Journal of Public Health Management and Practice is published by Lippincott Williams & Wilkins, a Wolters Kluwer Health company.
Although the 2009 H1N1 influenza pandemic infected an estimated 60 million people and hospitalized more than 250,000 in the United States, it also brought one significant benefit—clues about how to make a vaccine that could protect against multiple strains of influenza.
According to the critical care experts at The Johns Hopkins Hospital who treated him, Allen Bagents, 24, of Arlington, Va., is the least likely person anyone ever expects to get sick, let alone suffer a six-week, potentially fatal bout with the swine flu, better known as H1N1 influenza.
Results of a study conducted by researchers at Georgia Tech and the CDC suggest that strengthening routine influenza vaccination and health programs may help states improve their vaccination coverage against future pandemics or other health emergencies.
The H1N1 influenza pandemic has led to a sharp increase in the number of children with a serious "secondary" bacterial infection called empyema in children, suggests a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
As the weather turns brisk and flu season begins, bad memories of last year’s H1N1pandemic may start surfacing. Luckily, microbiologist John Tudor, Ph.D., professor of biology at Saint Joseph’s University in Philadelphia, anticipates a less violent outbreak of the virus this year.
Recent studies show most egg-allergic individuals can receive the flu vaccine safely under the care of their allergist or immunologist.
The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible.
Johns Hopkins has a wide range of experts available for interviews and comments about seasonal flu, H1N1, emergency preparedness, infection control, flu transmission in children, vaccine safety, flu treatment, public health ethics, flu in cancer patients, and related public communications strategies. If you would like to interview a Johns Hopkins expert, call or e-mail the designated information officer in the list below.
As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.
Public health officials have long believed that notifying the public about outbreaks of infectious disease could help reduce transmission rates and the overall impact of a pandemic. Now, researchers have modified the most widely used infectious disease model to account for the impact of media coverage.
Fears over the influenza A virus (H1N1; sometimes referred to as swine flu) have motivated researchers to investigate the antimicrobial activity of the Aganocide® compounds against viruses.
An analysis of data from influenza cases in Wisconsin indicates individuals with 2009 H1N1 infections were younger than those with H3N2 (2007-2008), and that the risk of most serious complications was not higher in adults or children with 2009 H1N1 compared with recent seasonal strains, according to a study in the September 8 issue of JAMA.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right